CWS Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $986K | Sell |
5,315
-661
| -11% | -$123K | 0.29% | 43 |
|
|
2025
Q1 | $1.25M | Buy |
5,976
+416
| +7% | +$87.2K | 0.4% | 37 |
|
|
2024
Q4 | $988K | Buy |
5,560
+739
| +15% | +$131K | 0.32% | 39 |
|
|
2024
Q3 | $952K | Hold |
4,821
| – | – | 0.34% | 34 |
|
|
2024
Q2 | $827K | Buy |
4,821
+350
| +8% | +$60K | 0.33% | 34 |
|
|
2024
Q1 | $814K | Sell |
4,471
-975
| -18% | -$178K | 0.33% | 32 |
|
|
2023
Q4 | $844K | Buy |
5,446
+132
| +2% | +$20.5K | 0.32% | 46 |
|
|
2023
Q3 | $792K | Buy |
5,314
+589
| +12% | +$87.8K | 0.32% | 51 |
|
|
2023
Q2 | $637K | Sell |
4,725
-1,152
| -20% | -$155K | 0.24% | 65 |
|
|
2023
Q1 | $937K | Buy |
5,877
+420
| +8% | +$66.9K | 0.37% | 39 |
|
|
2022
Q4 | $591K | Sell |
5,457
-831
| -13% | -$90K | 0.25% | 65 |
|
|
2022
Q3 | $844K | Buy |
6,288
+338
| +6% | +$45.4K | 0.4% | 36 |
|
|
2022
Q2 | $911K | Sell |
5,950
-711
| -11% | -$109K | 0.42% | 35 |
|
|
2022
Q1 | $1.08M | Buy |
6,661
+148
| +2% | +$24K | 0.41% | 33 |
|
|
2021
Q4 | $882K | Buy |
+6,513
| New | +$882K | 0.31% | 57 |
|
|
2021
Q2 | $626K | Buy |
5,562
+105
| +2% | +$11.8K | 0.25% | 67 |
|
|
2021
Q1 | $591K | Buy |
5,457
+19
| +0.3% | +$2.06K | 0.25% | 65 |
|
|
2020
Q4 | $583K | Sell |
5,438
-182
| -3% | -$19.5K | 0.34% | 60 |
|
|
2020
Q3 | $492K | Sell |
5,620
-707
| -11% | -$61.9K | 0.33% | 63 |
|
|
2020
Q2 | $621K | Buy |
6,327
+798
| +14% | +$78.3K | 0.45% | 47 |
|
|
2020
Q1 | $490K | Hold |
5,529
| – | – | 0.36% | 62 |
|
|
2019
Q4 | $490K | Buy |
+5,529
| New | +$490K | 0.36% | 63 |
|